Tan Kevin
SEC CIK 1884056 · EDGAR
BoughtSold
Most active insiders at SLDB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cumbo Alexander | Pres, CEO, Dir | — | $984.0K |
| 2 | Howton David T | COO | — | $433.6K |
| 3 | Tan Kevin | CFO, Treas | — | $329.5K |
| 4 | Hanrahan Jessie | Chief Regulatory Off | — | $297.4K |
| 5 | Brooks Gabriel | Chief Medical Off | — | $281.0K |
| 6 | Herzich Paul | CTO | — | $274.1K |
| 7 | Ganot Ilan | Dir | — | $82.4K |
| 8 | SMITH IAN F | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-18 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $5.82 | -5,404 | 99.4K | -5% | -$31.5K |
| DT | 2026-02-18 | 2026-02-13 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +10.6K | 104.8K | +11% | — |
| T | 2026-02-06 | 2026-02-04 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale | $6.44 | -14.8K | 94.2K | -14% | -$95.2K |
| DMT | 2026-02-02 | 2026-01-29+ | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +89.7K | 135.8K | +195% | — |
| DT | 2026-02-02 | 2026-02-02 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $6.44 | -26.8K | 109.0K | -20% | -$172.8K |
| DT | 2026-01-13 | 2026-01-09 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +11.2K | 51.8K | +28% | — |
| DT | 2026-01-13 | 2026-01-13 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $5.27 | -5,704 | 46.1K | -11% | -$30.1K |
| DT | 2025-02-18 | 2025-02-13 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +10.6K | 35.4K | +43% | — |
| DT | 2025-02-18 | 2025-02-14 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $3.96 | -3,164 | 32.2K | -9% | -$12.5K |
| D | 2025-01-13 | 2025-01-10 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $3.89 | -4,073 | 24.8K | -14% | -$15.8K |
| D | 2025-01-13 | 2025-01-09 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +11.2K | 28.9K | +64% | — |
| D | 2024-01-11 | 2024-01-09 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | S - Sale+OE | $8.20 | -3,935 | 9,308 | -30% | -$32.3K |
| D | 2024-01-11 | 2024-01-09 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treas | M - OptEx | — | +11.2K | 13.2K | +564% | — |
| D | 2022-01-05 | 2022-01-03 | RNAC | Cartesian Therapeutics, Inc. | Tan Kevin | CFO | A - Grant | $0.00 | +72.0K | 77.0K | +1,440% | $0 |
| 2021-12-06 | 2021-12-02 | RNAC | Cartesian Therapeutics, Inc. | Tan Kevin | CFO | P - Purchase | $3.03 | +5,000 | 5,000 | New | +$15.1K |
Purchase Sale Sale after option exercise All abbreviations